Marcos Berry

ORCID: 0000-0002-6562-7950
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Bariatric Surgery and Outcomes
  • Gastric Cancer Management and Outcomes
  • Diet and metabolism studies
  • Minimally Invasive Surgical Techniques
  • Esophageal and GI Pathology
  • Pharmacology and Obesity Treatment
  • Obesity and Health Practices
  • Pancreatitis Pathology and Treatment
  • Surgical Simulation and Training
  • Lipid metabolism and disorders
  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Obesity, Physical Activity, Diet
  • Palliative Care and End-of-Life Issues
  • Adipokines, Inflammation, and Metabolic Diseases
  • Anesthesia and Pain Management
  • Child Nutrition and Feeding Issues
  • Intestinal Malrotation and Obstruction Disorders
  • Fibroblast Growth Factor Research
  • Vitamin D Research Studies
  • Gastroesophageal reflux and treatments
  • Health and Lifestyle Studies
  • Organ Transplantation Techniques and Outcomes
  • Body Contouring and Surgery
  • Diabetes Treatment and Management

Clínica Las Condes
2010-2024

All India Institute of Medical Sciences
1987

Objective: To define “best possible” outcomes for bariatric surgery (BS)(Roux-en-Y gastric bypass [RYGB] and sleeve gastrectomy [SG]). Background: Reference values optimal surgical in well-defined low-risk patients have not been established so far. Consequently, outcome comparison across centers over time is impeded by heterogeneity case-mix. Methods: Out of 39,424 elective BS performed 19 high-volume academic from 3 continents between June 2012 May 2017, we identified 4120 RYGB 1457 SG...

10.1097/sla.0000000000003512 article EN Annals of Surgery 2019-10-07

Laparoscopic sleeve gastrectomy (LSG) in patients with a BMI between 30 and 35 kg/m2 plus comorbidities has shown to be safe effective. The purpose of this study is describe our outcomes group after 3 years follow-up. Retrospective descriptive analysis initial were submitted LSG 2006 2013. We analyzed gender, age, comorbidities, BMI, total weight loss (%TWL), excess (%EWL), comorbidity resolution, morbidity, mortality. Postoperative success was defined as %TWL over 20% EWL% 50% maintained...

10.1007/s11695-017-2897-x article EN cc-by Obesity Surgery 2017-10-04

Between 1976 and 1984, 136 patients with portal hypertension due to extrahepatic obstruction were operated on. Twenty two had emergency 114 elective operations. The operative mortality was 9% 1%, respectively. Altogether 117 (86%) followed up for from 10 years: 17 rebled, none developed encephalopathy or sepsis after splenectomy, 90% 75% alive at five years Unlike endoscopic sclerotherapy treatment propranolol, of variceal bleeding can usually be completed during one admission carries a low...

10.1136/bmj.295.6606.1115 article EN BMJ 1987-10-31

Obesity is one of the largest problems in public health worldwide today. For patients with severe obesity and associated comorbidities, surgical treatment recommended.To analyze frequency micronutrient deficiencies food intake at least 12 months after sleeve gastrectomy (SG).This a cross sectional study carried out between October December 2009 measure serum levels vitamin B12, D, folate, calcium, ferritin, zinc, parathyroid hormone bone mineral density on underwent SG before study. A...

10.3305/nh.2014.29.1.7039 article EN PubMed 2014-01-01

The mechanism leading to the development of metabolic complications in obese individuals is not fully understood. Thus, objective this study was examine differences insulin resistance, inflammation, cytokine and adipokine levels, expression selected genes across with different number syndrome (MetS) components.Forty who underwent bariatric surgery, divided three groups based on components MetS, addition abdominal obesity (0, 1, 2-3 additional components), were studied. Levels inflammatory...

10.1089/met.2016.0104 article EN Metabolic Syndrome and Related Disorders 2017-01-11

Obesity and related metabolic disorders are increasing especially in developing countries. It is widely accepted that extremely obese patients bariatric surgery reduces body weight improves type 2 diabetes the syndrome. Weight loss partially explains this effect as do loss-independent mechanisms linked to gut hormones, peptide YY, ghrelin, glucagon-like peptide-1, glucose-dependent insulinotropic peptide/gastric inhibitory polypeptide. Several groups performing established novel surgical...

10.1177/1474651410370302 article EN The British Journal of Diabetes 2010-05-01

Medical devices benefit patients living with overweight or obesity, but studies in the adolescent population are lacking. The goal of this study was to collect information on performance and safety a swallowable intragastric balloon program (SGBP) patients.

10.1007/s11695-024-07458-0 article EN cc-by-nc-nd Obesity Surgery 2024-08-28

La ketamina se ha utilizado en dosis sub-anestésicas pacientes no obesos sugiriendo que su uso disminuye el consumo de morfina postoperatoria, sin embargo, la evidencia literatura es contradictoria. Determinar efecto intraoperatoria durante las primeras 24 horas postoperatorias operados manga gástrica laparoscópica. Ensayo Clínico Controlado, Aleatorizado, doble ciego grupos paralelos unicéntrico realizado entre septiembre del 2015 y Enero 2017. Se incluyeron 18 60 años ambos sexos, con...

10.1016/j.rmclc.2018.10.004 article ES cc-by-nc-nd Revista Médica Clínica Las Condes 2018-11-01

10.1016/j.soard.2019.08.499 article EN Surgery for Obesity and Related Diseases 2019-10-01

10.1016/j.soard.2005.03.096 article EN Surgery for Obesity and Related Diseases 2005-05-01
Coming Soon ...